Navigation Links
Nektar Presents Positive Proof-of-Concept Clinical Data for Its New Opioid Molecule, NKTR-181, at American Academy of Pain Medicine's 28th Annual Meeting
Date:2/27/2012

to this new mu-opioid analgesic molecule is that it does not rely on a formulation to decrease its abuse liability. With a ten-fold slower entry into the brain as compared to oxycodone, NKTR-181 avoids the rush into the brain associated with euphoria.  Adding to our excitement is the data that shows the peripheral analgesic and anti-hyperalgesic effects of NKTR-181 in multiple pain models. We will seek to capitalize on the properties of this unique molecule as we advance NKTR-181 into Phase 2 development this year."

In a separate presentation of preclinical data at the AAPM Meeting, NKTR-181 resulted in less sedation and abuse liability as compared to oxycodone in multiple animal models across a wide range of doses.  As predicted from its molecular design, NKTR-181 has a reduced rate of entry into the brain in rodents.  This feature contributed to a 30-fold shift in the dose-response for abuse liability and a 10-fold shift in the dose response for sedation relative to oxycodone.

Chronic pain conditions, such as osteoarthritis, back pain and cancer pain, affect at least 126 million adults in the U.S. annually and contribute to over $100 billion a year in lost productivity.(2) 

About the NKTR-181 Phase 1 Multiple Ascending Dose Study

This Phase 1, double-blind, randomized, placebo-controlled, ascending multiple dose study of NKTR-181 was conducted in the U.S. at Lifetree Clinical Research. The study enrolled a total of 60 healthy subjects over an eight-day treatment period.  Four dose cohorts were evaluated with 15 subjects in each dose cohort (100 mg, 200 mg, 300 mg, 400 mg).  Subjects in each cohort received oral twice-daily doses of NKTR-181 (n=12) in aqueous solution or placebo (n=3) following an overnight fast.  Pharmacokinetics were determined through serial blood samples. Serial opioid pharmacodynamic tests included the cold-pressor test (CPT) and a UVB injury model to assess both central
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2011 on Wednesday, February 29, 2012, After Close of U.S.-Based Financial Markets
2. Positive Data for Nektars New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011
3. Nektar Therapeutics Reports Third Quarter 2011 Financial Results
4. Nektar to Announce Financial Results for the Third Quarter of 2011 on Wednesday, November 2, 2011, After Close of U.S.-Based Financial Markets
5. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the UBS 2011 Global Life Sciences Conference in New York City
6. Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain
7. Nektar Therapeutics Reports Second Quarter 2011 Financial Results
8. Nektar to Announce Financial Results for the Second Quarter of 2011 on Thursday, August 4, 2011, After Close of U.S.-Based Financial Markets
9. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2011 Global Healthcare Conference in New York
10. Nektar Announces New Phase 2 Data for NKTR-102 to Be Presented at 2011 ASCO Annual Meeting
11. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... 18, 2013 Although colonoscopy exams prevent many ... most sensitive method for detecting colorectal cancers 2 , ... cases 3 . EndoChoice ® Inc. today unveiled ... improves the accuracy of this procedure and greatly reduces ... be discussing these clinical trial results and featuring the ...
(Date:5/17/2013)... 17, 2013  Lakeland Industries, Inc. (NASDAQ: ... for industry, healthcare and to first responders on the ... results for the fiscal 2013 fourth quarter and year ... at stock market close and will conduct a conference ... (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced the ... and 130um sorting chip.  Sony will also be exhibiting its ... SH800 Cell Sorter, the EC800 flow cytometer, and new SP6800 ... 2013, which will be held at the San ... California , from May 20 - 22.  ...
Breaking Medicine Technology:New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Sony Delivers New Technology for Science to CYTO 2013 2
... N.J., April 26, 2011 Protect Pharmaceutical Corporation (OTCBB: ... current Chief Operating Officer Ramesha Sesha as its Chief ... Mr. Sesha joined Protect as the Chief Operating Officer ... Acquisition Agreement with Nectid Inc where he was the ...
... DUBLIN, April 26, 2011 Amarin Corporation plc (Nasdaq: ... on cardiovascular disease, today announced that John Thero, Amarin,s President, ... to be held at the InterContinental Hotel in Boston. The ... 2011. A live Webcast of the presentation will be available ...
Cached Medicine Technology:Protect Pharmaceutical Corporation Appoints Chief Executive Officer and Chief Financial Officer 2Amarin to Present at the Deutsche Bank 26th Annual Healthcare Conference 2
(Date:5/19/2013)... According to a May 14th, 2013 Harper’s ... self-conscious about the appearance of certain areas of the body. ... exercise fail to tone and tighten these areas. The report ... to get the firmest body possible (article: goo.gl/tPiha). ... Dr. Simon Ourian, Medical Director of Epione Beverly Hills. “I ...
(Date:5/19/2013)... FL (PRWEB) May 19, 2013 Omaha, Nebraska ... is also a city with one of the lowest unemployment ... it eleventh in their Best Places for Business and Careers ... Relocation lists. Omaha is centrally located in the nation ... of industry located there. The producers of Editions TV ...
(Date:5/19/2013)... In partnership with the medical practice online marketing company, ... an SEO website for dentists. The purpose of the site ... http://www.e-dentists.com/ , A perk to the service is ... see results. Dentists can request the keywords they want included ... Media Surge, LLC rank high for competitive keywords. Dentists can ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 The muscles ... for their functionality and one of the biggest and ... peripheral nervous system. The peripheral system comprises of peripheral ... spinal cord. These nerves ensure that the limbs and ... However, when these nerves get damaged due to trauma ...
(Date:5/19/2013)... 2013 Grinding your teeth at night ... or annoying your spouse. At the same time, according ... (“Snoring and Teeth Grinding Could Be a Sign of ... can be hard to prevent. Apparently, Obstructive Sleep Disorder ... of its symptoms is a habit of teeth grinding ...
Breaking Medicine News(10 mins):Health News:Body Firming – The Hottest Treatments Available 2Health News:Editions TV Announces May Air Dates for Omaha, Nebraska 2Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3
... USAID to Invest US $50 Million over a ... Planning, RESEARCH TRIANGLE PARK, N.C., June 20 ... announced that Family,Health International (FHI) -- a global ... major family planning research project known as,PROGRESS (Program ...
... they are too fat is worse than for adolescents ... the all Germany Health Interview and Examination Survey for ... as presented by Brbel-Maria Kurth and Ute Ellert in ... (Dtsch Arztebl Int 2008, 105[23]: 406-12). , http://www.aerzteblatt.de/v4/archiv/pdf.asp?id=60382 ...
... is available in Spanish . , A PhD ... that there are opioid and cannabinoid receptors in ... The research by Mr Ekaitz Agirregoitia opens the door to ... released spermatozoids cannot achieve fertilisation, they must undergo some changes ...
... scientists have shown that mental and physical exercise ... syndrome, a devastating genetic brain development disorder that ... of Rett syndrome developed by the Children,s Medical ... Florey Institute in Melbourne found these mice responded ...
... Northern Response to start selling Xflowsion at the Electronic ... Shopping Conference in ... uKarma Corporation (OTC,Bulleting Board: UKMA), a lifestyle multimedia and ... announced,today that its exclusive international distributor, Northern Response,(International), Ltd., ...
... SCHAUMBURG, Ill., June 20 Major League Baseball (MLB),and ... up,with the American Academy of Dermatology (Academy) this summer ... fans about skin cancer.,The many hours spent in the ... puts both players and fans at risk for skin ...
Cached Medicine News:Health News:Family Health International Awarded USAID 'Progress' Project to Improve Family Planning and Reproductive Health Programs in Developing Countries 2Health News:Family Health International Awarded USAID 'Progress' Project to Improve Family Planning and Reproductive Health Programs in Developing Countries 3Health News:'Feeling fat' is worse than being it 2Health News:Opioids and cannabinoids influence mobility of spermatozoids 2Health News:Opioids and cannabinoids influence mobility of spermatozoids 3Health News:Mental and physical exercise improves genetic mental impairment 2Health News:uKarma Corporation Commences International Distribution Agreement With Northern Response for its Xflowsion DVD Series 2Health News:uKarma Corporation Commences International Distribution Agreement With Northern Response for its Xflowsion DVD Series 3Health News:American Academy of Dermatology, Major League Baseball and Major League Baseball Players Association Play Sun Smart(TM) to Strike Out Skin Cancer 2Health News:American Academy of Dermatology, Major League Baseball and Major League Baseball Players Association Play Sun Smart(TM) to Strike Out Skin Cancer 3Health News:American Academy of Dermatology, Major League Baseball and Major League Baseball Players Association Play Sun Smart(TM) to Strike Out Skin Cancer 4
... includes kits that quantitatively measure two important ... An elevated serum or plasma homocysteine level ... independent risk factor for cardiovascular disease. And ... associated elevated levels of Lp(a) with increased ...
... a leading provider of immunofluorescence assays, with ... that includes kits for autoimmune diseases, infectious ... conjugates and components. Our Impact IFA Test ... substrates and kit sizes to choose from. ...
... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
... Inverness Medical Professional Diagnostics is a leading ... IFA and DFA test menu that includes ... STDs as well as miscellaneous conjugates and ... you a wide assortment of substrates and ...
Medicine Products: